UP!
| 2016-05-04 | Downgrade | WallachBeth Capital | Buy to Hold | |
| 2016-05-04 | Reiterated Rating | JPMorgan Chase & Co. | Hold | |
| 2016-03-10 | Reiterated Rating | Needham & Company LLC | Hold | |
| 2016-02-29 | Downgrade | RBC Capital | Outperform to Sector Perform | $4.00 to $1.00 |
| 2016-02-29 | Downgrade | Royal Bank Of Canada | Outperform to Sector Perform | $4.00 to $1.00 |
| 2015-11-05 | Upgrade | WallachBeth Capital | Hold to Buy | $2.30 to $2.80 |
| 2015-09-09 | Reiterated Rating | RBC Capital | Buy | |
| 2015-08-03 | Reiterated Rating | WallachBeth Capital | Hold | $2.30 |
| 2015-08-02 | Reiterated Rating | RBC Capital | Buy | |
| 2015-07-31 | Reiterated Rating | Needham & Company LLC | Hold | |
| 2015-07-31 | Lower Price Target | RBC Capital | Outperform | $6.00 to $4.00 |
| 2015-05-09 | Reiterated Rating | RBC Capital | Outperform | |
| 2015-05-06 | Set Price Target | RBC Capital | Buy | $6.00 |
| 2015-02-25 | Reiterated Rating | Needham & Company LLC | Hold | |
| 2015-01-22 | Initiated Coverage | RBC Capital | Outperform | $6.00 |
| 2014-11-06 | Reiterated Rating | Bank of America | Underperform | $4.00 to $3.00 |
| 2014-11-06 | Reiterated Rating | Bank of America Corp. | Underperform | $4.00 to $3.00 |
| 2014-09-04 | Initiated Coverage | Credit Suisse | Neutral | |
| 2014-09-04 | Initiated Coverage | Credit Suisse Group AG | Neutral | |
| 2014-05-06 | Lower Price Target | JPMorgan Chase & Co. | Neutral | $8.00 to $5.00 |
| 2014-05-06 | Lower Price Target | Credit Suisse | $7.00 to $6.00 | |
| 2014-04-24 | Initiated Coverage | Wells Fargo & Co. | Market Perform | |
| 2014-04-24 | Initiated Coverage | Wells Fargo | Market Perform | |
| 2014-04-03 | Lower Price Target | Citigroup Inc. | Neutral to Underweight | $8.00 to $3.00 |
| 2014-04-03 | Downgrade | Piper Jaffray | Neutral to Underweight | $8.00 to $3.00 |
| 2014-02-25 | Reiterated | WallachBeth | Hold | $11 to $8 |
| 2014-02-25 | Lower Price Target | WallachBeth Capital | Hold | $11.00 to $8.00 |
| 2014-02-25 | Lower Price Target | Jefferies Group | $5.00 to $2.00 | |
| 2014-02-25 | Lower Price Target | Credit Suisse | $10.00 to $7.00 | |
| 2014-02-25 | Lower Price Target | Brean Capital | $5.00 to $4.00 | |
| 2014-02-25 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $15.00 to $8.00 |
| 2014-02-25 | Downgrade | Bank of America | Neutral to Underperform | $11.00 to $6.00 |
| 2013-11-15 | Initiated Coverage | WallachBeth Capital | Hold | $11.00 |
| 2013-11-06 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $18.00 |
| 2013-11-06 | Lower Price Target | Credit Suisse | Neutral | $14.00 to $10.00 |
| 2013-11-06 | Lower Price Target | Brean Capital | Sell | $6.00 to $5.00 |
| 2013-11-06 | Downgrade | Bank of America | Buy to Neutral | $17.00 to $11.00 |
| 2013-10-16 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $22.00 to $18.00 |
| 2013-10-16 | Downgrade | Piper Jaffray | Overweight to Neutral | $14.00 to $11.00 |
| 2013-10-11 | Reiterated Rating | Leerink Swann | Outperform | $20.00 |
| 2013-10-03 | Reiterated Rating | Leerink Swann | Outperform | |
| 2013-10-03 | Upgrade | Cowen and Company | Market Perform to Outperform | $13.50 to $19.00 |
| 2013-10-02 | Reiterated Rating | Bank of America | Buy | $17.00 |
| 2013-07-19 | Downgrade | Needham | Buy to Hold | |
| 2013-01-18 | Reiterated | MLV & Co | Buy | $40 to $21 |
| 2012-09-24 | Reiterated | Needham | Buy | $38 to $32 |
| 2012-07-19 | Reiterated | MLV & Co | Buy | $34 to $40 |
| 2012-07-18 | Reiterated | Rodman & Renshaw | Mkt Outperform | $39 to $52 |
| 2012-07-18 | Downgrade | Brean Murray | Buy to Hold | |
| 2012-04-30 | Reiterated | MLV & Co | Buy | $30 to $34 |
| 2012-02-23 | Upgrade | Rodman & Renshaw | Mkt Perform to Mkt Outperform | $39 |
| 2012-02-23 | Reiterated | MLV & Co | Buy | $22 to $30 |
| 2012-01-17 | Reiterated | MLV & Co | Buy | $16 to $22 |
| 2010-10-29 | Reiterated | JMP Securities | Mkt Outperform | $12 to $16 |
| 2010-07-16 | Reiterated | Wedbush | Outperform | $20 to $10 |
| 2016-05-04 | Downgrade | WallachBeth Capital | Buy to Hold | |
| 2016-05-04 | Reiterated Rating | JPMorgan Chase & Co. | Hold | |
| 2016-03-10 | Reiterated Rating | Needham & Company LLC | Hold | |
| 2016-02-29 | Downgrade | RBC Capital | Outperform to Sector Perform | $4.00 to $1.00 |
| 2016-02-29 | Downgrade | Royal Bank Of Canada | Outperform to Sector Perform | $4.00 to $1.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In VVUS 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| NORTH TIDE CAPITAL, LLC | 10.12% (10466700) | AFAM / AMED / ELOS / HWAY / SEM / VVUS / |
| DENNER ALEXANDER J See Footnotes Below | 2.49% (2573943) | APRI / ARIA / BIIB / ENZN / MDCO / MSTX / VVUS / |
| Colin Samuel F | 2.48% (2565979) | VVUS / |
| Fischer Seth H.Z. Chief Executive Officer | 0.61% (633978) | AGRX / MRNS / VVUS / |
| Slebir John L VP, General Counsel | 0.13% (134010) | VVUS / |
| Sanford Svai S Interim CFO | 0.12% (128359) | VVUS / |
| WILSON LELAND F Chief Executive Officer | 0.12% (119112) | VVUS / |
| Plutzky Jorge MD | 0.08% (81159) | AEGR / QLTI / VVUS / |
| MARIO ERNEST | 0.08% (81125) | BSX / CAPN / CELG / CMRX / KIN / TNXP / VVUS / XNPT / |
| Roberts Eric W | 0.07% (76888) | VVUS / |
| Varghese Santosh T VP, Medical & Reg Affairs | 0.07% (71415) | VVUS / |
| Norton David Y | 0.06% (67120) | INCR / MNK / VVUS / |
| ROSENMAN HERM | 0.06% (61671) | OXFD / VVUS / |
| Shaw Allan | 0.06% (59125) | CLTX / VVUS / |
| LOGAN MARK B | 0.05% (53000) | STAA / VVUS / |
| Day Wesley VP, Clinical Development | 0.05% (46569) | VVUS / |
| TAM PETER Y President | 0.04% (37629) | VVUS / |
| MARSH GUY P VP, Operations & General Mgr. | 0.03% (30854) | VVUS / |
| CASAMENTO CHARLES J | 0.03% (26125) | AZRX / VVUS / |
| WILSON ROBERT N | 0.02% (25650) | HES / SCHW / SNTA / VVUS / |
| Sris Mayu | 0.02% (22918) | VVUS / |
| CARROLL J MARTIN | 0.02% (20000) | CTLT / DRTX / MNK / TXMD / VVUS / |
| ASTRUE MICHAEL J | 0.01% (10000) | VVUS / |
| MILLER MICHAEL PATRICK Chief Commercial Officer | 0.01% (7943) | JAZZ / PBYI / VVUS / |
UM